Liver Resection for Nonalcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma

被引:51
|
作者
Koh, Ye Xin [1 ]
Tan, Hiang Jin [1 ]
Liew, Yi Xin [2 ]
Syn, Nicholas [1 ]
Teo, Jin Yao [1 ,4 ]
Lee, Ser Yee [1 ,4 ]
Goh, Brian K. P. [1 ,4 ]
Goh, George B. B. [3 ,4 ]
Chan, Chung Yip [1 ,4 ]
机构
[1] Singapore Gen Hosp, Dept Hepatopancreatobiliary & Transplant Surg, 20 Coll Rd, Singapore 169856, Singapore
[2] Singapore Gen Hosp, Dept Pharm, Singapore, Singapore
[3] Singapore Gen Hosp, Dept Gastroenterol & Hepatol, Singapore, Singapore
[4] Duke Natl Univ Singapore, Singapore, Singapore
关键词
NAFLD; STEATOHEPATITIS; SURVIVAL;
D O I
10.1016/j.jamcollsurg.2019.07.012
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD)-related hepatocellular carcinoma (HCC) is on the rise worldwide, but data on long-term outcomes after curative operations are limited. The primary aim of this study was to characterize the perioperative and long-term outcomes after liver resection. The secondary aim was to investigate the influence of the histologic severity of nonalcoholic steatohepatitis and its impact on perioperative outcomes and long-term survival. METHODS: A total of 996 patients who underwent liver resection for HCC in our institution were analyzed. Patients were categorized into subgroups of NAFLD vs non-NAFLD HCC based on histologic evidence of hepatic steatosis. Comparisons of patients' demographic, clinical, and surgical characteristics; postoperative complications; and survival outcomes were performed. RESULTS: Eight hundred and forty-four patients had non-NAFLD HCC and 152 patients had NAFLD HCC. Comorbidities were significantly more common in the NAFLD group (p < 0.0001). In the non-NAFLD group, larger median tumor size, higher liver cirrhosis, and lower median neutrophil to lymphocyte ratio were observed (p < 0.0001). The NAFLD group had a greater amount of intraoperative blood loss, more postoperative complications, and longer length of stay. Five-year overall survival was significantly better in the NAFLD group (p = 0.0355). Significant factors that contribute to poorer survival outcomes include age, congestive cardiac failure, Child-Pugh's class B, cirrhosis, tumor size, multinodularity, and R1 resection. For NAFLD group, patients with abnormal parenchyma showed poorer survival and 5-year overall survival rates (64.8% vs 75.6%; p = 0.2291). CONCLUSIONS: Nonalcoholic fatty liver disease-related HCC is associated with greater surgical morbidity and post-hepatectomy liver failure. Despite this, long-term survival outcomes are favorable compared with non-NAFLD etiologies. ((C) 2019 by the American College of Surgeons. Published by Elsevier Inc. All rights reserved.)
引用
收藏
页码:467 / +
页数:13
相关论文
共 50 条
  • [21] Nonalcoholic Fatty Liver Disease, Diabetes, Obesity, and Hepatocellular Carcinoma
    Noureddin, Mazen
    Rinella, Mary E.
    CLINICS IN LIVER DISEASE, 2015, 19 (02) : 361 - +
  • [22] Hepatocellular carcinoma surveillance in nonalcoholic fatty liver disease patients
    Truong, Emily
    Noureddin, Mazen
    HEPATOMA RESEARCH, 2022, 8
  • [23] Surgical Outcomes for Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
    Toshifumi Wakai
    Yoshio Shirai
    Jun Sakata
    Pavel Vladimirovich Korita
    Yoichi Ajioka
    Katsuyoshi Hatakeyama
    Journal of Gastrointestinal Surgery, 2011, 15 : 1450 - 1458
  • [24] Hepatocellular carcinoma in nonalcoholic fatty liver disease: A growing challenge
    ?ngelo Z Mattos
    Jose D Debes
    Renu Dhanasekaran
    Jihane N Benhammou
    Marco Arrese
    André Luiz V Patrício
    Amanda C Zilio
    Angelo A Mattos
    World Journal of Hepatology, 2021, 13 (09) : 1107 - 1121
  • [25] Surgical Outcomes for Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
    Wakai, Toshifumi
    Shirai, Yoshio
    Sakata, Jun
    Korita, Pavel Vladimirovich
    Ajioka, Yoichi
    Hatakeyama, Katsuyoshi
    JOURNAL OF GASTROINTESTINAL SURGERY, 2011, 15 (08) : 1450 - 1458
  • [26] Hepatocellular carcinoma in nonalcoholic fatty liver disease: A growing challenge
    Mattos, Angelo Z.
    Debes, Jose D.
    Dhanasekaran, Renu
    Benhammou, Jihane N.
    Arrese, Marco
    Patricio, Andre Luiz, V
    Zilio, Amanda C.
    Mattos, Angelo A.
    WORLD JOURNAL OF HEPATOLOGY, 2021, 13 (09) : 1107 - 1121
  • [27] Expected increase of hepatocellular carcinoma by nonalcoholic fatty liver disease
    Alt, Y.
    Schattenberg, J. M.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2016, 54 (04): : 364 - 365
  • [28] Predictors of hepatocellular carcinoma development in nonalcoholic fatty liver disease
    Yuan, Jian-Min
    Wang, Renwei
    Luu, Hung N.
    Behari, Jaideep
    CANCER RESEARCH, 2022, 82 (12)
  • [29] Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma: A Weighty Connection
    Starley, Brad Q.
    Calcagno, Christopher J.
    Harrison, Stephen A.
    HEPATOLOGY, 2010, 51 (05) : 1820 - 1832
  • [30] Screening and interventions to prevent nonalcoholic fatty liver disease/nonalcoholic steatohepatitis-associated hepatocellular carcinoma
    Simona Cernea
    Danusia Oni?or
    World Journal of Gastroenterology, 2023, 29 (02) : 286 - 309